# Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension

> **NCT00237783** · PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 4 (actual)

## Conditions studied

- Hemodialysis
- Hypotension

## Interventions

- **DRUG:** dialysate sodium (140 mmol/L)
- **DRUG:** individualized dialysate sodium

## Key facts

- **NCT ID:** NCT00237783
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Unable to recruit enough subjects
- **Last updated:** 2016-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237783, "Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00237783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*